share_log

太龙药业最新公告:拟在云南设立全资子公司太龙本草

The latest announcement of Tai long Pharmaceutical Co., Ltd.: plans to set up a wholly-owned subsidiary Tai long Materia Medica in Yunnan

證券之星 ·  Jan 19, 2022 04:36

Tai long Pharmaceutical announced that the company intends to contribute 50 million yuan with monetary funds to set up a wholly owned subsidiary Tai long Materia Medica in Yunnan.

The chairman of the company is Li Jingliang. Mr. Li Jingliang: born in January 1969 with a master's degree, he once served as the general manager of the company, vice chairman of the company and chairman of Zhongsheng Group. He is currently the chairman of the company.

This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If you have any questions, please contact us.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment